Transcoronary Sinus Therapy for Coronary Microvascular Dysfunction.

Area of Science:

• Cardiology
• Vascular Medicine
• Interventional Cardiology

Background:

• Coronary microvascular disease (CMD) is linked to increased cardiovascular events and poorer outcomes after revascularization.
• CMD often coexists with epicardial disease, leading to reduced exercise tolerance and symptoms despite optimal treatment.
• Managing microvascular obstruction post-revascularization remains a significant clinical challenge.

Purpose of the Study:

• To review recent advancements in coronary sinus-based therapeutic approaches for coronary microvascular disease.
• To evaluate the efficacy and challenges of coronary sinus interventions in managing CMD.
• To discuss the potential of the coronary venous system for treating microvascular obstructions.

Main Methods:

• Review of current literature on coronary sinus interventions for CMD.
• Analysis of data on coronary sinus reducer and pressure-controlled intermittent coronary sinus occlusion.
• Examination of recent randomized trial findings comparing interventions.

Main Results:

• Coronary sinus interventions may benefit 70-80% of patients with refractory angina and CMD ineligible for revascularization.
• These interventions modulate coronary venous pressures, offering clinical aid.
• A recent trial showed no significant difference in infarct size reduction with pressure-controlled intermittent coronary sinus occlusion compared to conventional PCI.

Conclusions:

• Coronary sinus interventions represent a novel approach for CMD management.
• While promising for refractory angina, further research is needed to clarify efficacy, particularly regarding infarct size reduction.
• The coronary venous system offers a potential therapeutic avenue for complex coronary microvascular obstructions.